Sam Jactel

Sam Jactel is a dedicated individual with a passion for making scientific knowledge accessible to those in need.

His educational background includes a Master of Business Administration (MBA) from Northwestern University's Kellogg School of Management, a Bachelor's degree in Biology from Duke University, participation in the 2022 ADAPT Program at UCSF Rosenman Institute, a Bachelor of Science in Biology from UNSW, and an IB Bilingual Diploma from Atlanta International School.

Throughout his career, Sam has been associated with various esteemed organizations. He has served as an Invited Lecturer at Columbia University Mailman School of Public Health, Member of the Board of Directors at Hypercell Technologies, Strategic Advisor at Pertinent Eco-Solutions, Founder & CEO of Ayble Health, and in roles like Growth Strategy at Ginkgo Bioworks, Inc., Flare Scholar at Flare Capital Partners, Business Strategy Consultant at Accenture, Global Commercial Strategy at Genzyme, and Sr. Pathology Researcher at Children's Healthcare of Atlanta.